Back
Vertex Pharmaceuticals 10K Form
Buy
55
VRTX
Vertex Pharmaceuticals
Last Price:
467.43
Seasonality Move:
13.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2024-02-15 | 10K | VRTX/Vertex Pharmaceuticals Annual |
| 2023-11-07 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2023-08-02 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2023-05-02 | 10Q | VRTX/Vertex Pharmaceuticals Quarterly |
| 2023-02-10 | 10K | VRTX/Vertex Pharmaceuticals Annual |
Receive VRTX News And Ratings
See the #1 stock for the next 7 days that we like better than VRTX
VRTX Financial Statistics
Sales & Book Value
| Annual Sales: | $9.87B |
|---|---|
| Cash Flow: | $1.3B |
| Price / Cash Flow: | 0 |
| Annual Sales: | $60.65 |
| Price / Book: | 7.7 |
Profitability
| EPS (TTM): | -1.99000 |
|---|---|
| Net Income (TTM): | $-479.8M |
| Gross Margin: | $8.61B |
| Return on Equity: | -2.89% |
| Return on Assets: | -2.17% |
Vertex Pharmaceuticals Earnings Forecast
Key Vertex Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 33 years for VRTX is 87.21%.
- The Selling, General & Administrative Expenses for VRTX have been equal to 11.52% of Gross Profit Margin.
- The Research & Development expenses have been 32.05% of Revenue.
- The Interest Expense is 1.22% of Operating Income.
- The Net Earning history of VRTX is 36.68% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 14 years.
Vertex Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VRTX |
| CUSIP: | 92532F |
| Website: | vrtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.47 |
| Quick Ratio: | 2.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.63 |
|---|---|
| Forward P/E Ratio: | 24.86 |
VRTX Technical Analysis vs Fundamental Analysis
Buy
55
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $467.07. The Score for VRTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.